Dr Michelle Anne Fitzmaurice

Dr Michelle Fitzmaurice is a translational researcher specialising in metabolic signalling and glycation biology, with a focus on clinically relevant biomarker development. Her research examines how metabolic and hormonal signals are modified across biological systems, and how early molecular changes contribute to disease risk and progression. She integrates endocrinology, glycation biology and microbiome science to investigate how post-translational modifications and metabolic interactions influence health across the lifespan. Her work centres on developing analytically robust, clinically implementable biomarkers using routinely collected biospecimens and well-characterised patient cohorts, with applications in pregnancy, metabolic disease, neurodegeneration and healthy ageing. Dr Fitzmaurice is based within the Microbiome Research Centre, St George campus, School of Clinical Medicine, and holds cross-appointments supporting translational research, ethics and governance across hospital and university environments. microbiome, diabetes, developmental biology, Microbial genetics, Infant and child health, Endocrine organs and diseases (incl. diabetes)